Multimodal Prehabilitation Program for Women Undergoing Gynecologic Oncology Surgery
NCT ID: NCT07188662
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2024-04-23
2025-07-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Technological Based Rehabilitation Practices After Breast Cancer Surgery
NCT06156397
Long-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled Trial
NCT06913244
Oncological Safety of Oncoplastic Breast Surgery in Multicentric Breast Cancer
NCT06926335
Exercise Prehabilitation of Breast Cancer
NCT07240584
Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
NCT05889390
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional group
Conventional group (woman received hospital care at previous year as a retrospective sample to prevent risk of bias) equal 70 woman
No interventions assigned to this group
Prehabilitation group
Prehabilitation group (woman who will receive prehabilitation care combine with ERAS post-operative care as a prospective sample) equal 70 woman
group (B) Prehabilitation care combine with ERAS post-operative care
intervention will includes receiving prehabilitation care combine with ERAS post-operative care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
group (B) Prehabilitation care combine with ERAS post-operative care
intervention will includes receiving prehabilitation care combine with ERAS post-operative care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Accept participation in the study.
Exclusion Criteria
* Patient who received neoadjuvant chemotherapy
* Patient who have psychological disorder such as suicidal attempt
* Patient who have cerebral stroke, hemiplegia or paralyses
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aya M. Abdelhafez
lecturer of maternity, gynecological and obstetric nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aziza M Mohammed, Head nurse
Role: STUDY_CHAIR
Woman's Health Hospital, Assiut University, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Woman's Health Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMPPGOS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.